SCH50911 is a selective, orally active γ-aminobutyric acid B (GABA(B)) receptor antagonist that binds to GABA(B) receptors with an IC50 of 1.1 μM; it antagonizes GABA(B) autoreceptors and enhances electrically stimulated [3H] overflow with an IC50 of 3 μM.